Avadel Pharmaceuticals (NASDAQ:AVDL) Cut to "Sell" at Zacks Investment ResearchZolmax • over 2 years ago---
- Avadel Pharmaceuticals (NASDAQ:AVDL) was downgraded by Zacks Investment Research
from a hold rating to a sell rating in a report issued on Wednesday, Zacks.com reports.
According to Zacks, Avadel Pharmaceuticals plc is a specialty pharmaceutical company.
Its product pipeline consists of hospital and...